Literature DB >> 880974

Individual variation in the response to phenprocoumon.

S Husted, F Andreasen.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 880974     DOI: 10.1007/bf00566532

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  21 in total

1.  Protein binding of phenprocoumon in the absence and presence of furosemide.

Authors:  L Foged; S Husted; F Andreasen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-09

2.  Influence of nitrazepam on oral anticoagulation with phenprocoumon.

Authors:  R Bieger; H de Jonge; E A Loeliger
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

3.  Genetic control of dicumarol levels in man.

Authors:  E S Vesell; J G Page
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

4.  Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.

Authors:  A Yacobi; L B Wingard; G Levy
Journal:  J Pharm Sci       Date:  1974-06       Impact factor: 3.534

5.  Determinants of the response to coumarin anticoagulants in patients with acute myocardial infarction.

Authors:  P Ristola; K Pyörälä
Journal:  Acta Med Scand       Date:  1972-09

6.  Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate.

Authors:  E M Sellers; J Koch-Weser
Journal:  N Engl J Med       Date:  1970-10-15       Impact factor: 91.245

Review 7.  The pharmacological basis of oral anticoagulant therapy.

Authors:  P M Aggeler; R A O'Reilly
Journal:  Thromb Diath Haemorrh Suppl       Date:  1966

8.  Potential effect of the plasma on drug distribution.

Authors:  B K Martin
Journal:  Nature       Date:  1965-07-17       Impact factor: 49.962

9.  [Pharmacokinetic studies in increased reactivity to phenprocoumon (Marcumar)].

Authors:  H W Chriske; P von Smekal; M Knabe; D Kray
Journal:  Med Welt       Date:  1973-10-19

10.  [Pharmacokinetic studies on phenprocoumon (marcumar) resistance].

Authors:  H W Chriske; R Gross; H H Hilger; K Oette; P von Smekal; M Knabe; D Krey
Journal:  Verh Dtsch Ges Inn Med       Date:  1973
View more
  5 in total

1.  Factors responsible for interindividual differences in the dose requirement of phenprocoumon.

Authors:  D Trenk; H Althen; E Jähnchen; T Meinertz; S Oie
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Pharmacokinetics of furosemide in anephric patients and in normal subjects.

Authors:  F Andreasen; H E Hansen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

3.  The influence of age on the response to anticoagulants.

Authors:  S Husted; F Andreasen
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

Review 4.  Clinical pharmacokinetics of oral anticoagulants.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

Review 5.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.